Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02080143Not ApplicableTerminated

A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat Patches

Role: lead

NCT01841788Not ApplicableCompleted

Evaluation of Experimental Heat Patch

Role: lead

NCT01841801Not ApplicableCompleted

Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches

Role: lead

NCT02241057Not ApplicableCompleted

Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)

Role: lead

NCT01744106Phase 3Completed

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Role: collaborator

NCT01842711Completed

Cumulative Irritation Patch Test

Role: lead

All 6 trials loaded